← Back to Search

Visual Feedback Goggles for Positional Vertigo

Phase 1 & 2

Waitlist Available

Led By Philip F Anthony, MD

Research Sponsored by Vertigone Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Old patients (more than one year since first symptom) or new patients (more than 3 months duration of symptoms) diagnosed by physicians with Benign Paroxysmal Positional Vertigo (BPPV)

Subject is willing to remain in the clinic for the treatment and follow-up visits

Timeline

Screening 3 weeks

Treatment Varies

Follow Up this endpoint will also be measured twice, in the same manner as was srs.

Awards & highlights

Study Summary

This trial is a prospective, single-center, interventional study of the VertiGONE goggle in the treatment of BPPV. The study will enroll 100 subjects who will be randomized to either the VertiGONE goggle group or the control group. The primary outcome measure will be the resolution of vertigo, as measured by the Dizziness Handicap Inventory (DHI).

Who is the study for?

This trial is for people aged 30-80 with Benign Paroxysmal Positional Vertigo (BPPV), who have had symptoms for at least 3 months. Participants must be able to give informed consent, stay in the clinic for treatment and follow-ups, and have good neck flexibility to perform specific head movements.Check my eligibility

What is being tested?

The study tests two versions of a goggle that provides visual feedback during the Epley maneuver—a technique used to treat BPPV by repositioning particles in the inner ear. The goal is to see if better accuracy improves vertigo resolution.See study design

What are the potential side effects?

Since this trial involves non-invasive goggles designed to guide a physical maneuver without medication, side effects are minimal but may include temporary dizziness or discomfort from performing the Epley maneuver.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with BPPV for over 3 months or more than a year since my first symptom.

Select...

I am willing to stay in the clinic for treatment and follow-up visits.

Select...

I am between 30 and 80 years old.

Select...

I can move my neck freely to perform specific head movements.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ this endpoint will be measured twice: once following the baseline visit and again following the subsequent visit and treatment.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~this endpoint will be measured twice: once following the baseline visit and again following the subsequent visit and treatment.

This trial's timeline: 3 weeks for screening, Varies for treatment, and this endpoint will be measured twice: once following the baseline visit and again following the subsequent visit and treatment. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Symptom Relief Completeness (SRC): defined as the highest level (on the ordinal scale) of improvement attained during the allotted seven-day time period.

Symptom Relief Speed (SRS): defined as the number of days post-treatment until dizziness symptoms improve to category 5 (70-100% improvement from baseline).

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: 1 Goggle IExperimental Treatment1 Intervention

Optimized Goggle

Group II: 2 Google IIPlacebo Group1 Intervention

Goggle with 20 Degree error

0 / 4Eligibility criteria met

Find a Location

Who is running the clinical trial?

Vertigone Inc.Lead Sponsor

Philip F Anthony, MDPrincipal InvestigatorVertigone Inc.

Media Library

Visual Feedback Goggle Clinical Trial Eligibility Overview. Trial Name: NCT00729885 — Phase 1 & 2

Vertigo Research Study Groups: 1 Goggle I, 2 Google II

Vertigo Clinical Trial 2023: Visual Feedback Goggle Highlights & Side Effects. Trial Name: NCT00729885 — Phase 1 & 2

Visual Feedback Goggle 2023 Treatment Timeline for Medical Study. Trial Name: NCT00729885 — Phase 1 & 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this medical study accept participants aged 70 and above?

"This medical trial is seeking applicants aged between 30 to 80. For those under 18 and above 65, there are 3 trials for the former and 31 trials for the latter."

Answered by AI

Might I be eligible to participate in this clinical investigation?

"This clinical trial seeks 60 individuals aged 30-80 with vertigo. It is a requirement that the participants are either elderly (i.e., first symptom occurred more than one year prior) or recently diagnosed (more than 3 months duration of symptoms). The patient must have adequate cervical flexibility to allow for performance of the Epley maneuver and be willing to provide formal consent, remain in the clinic during treatment and follow up visits."

Answered by AI

Would any individuals be welcome to join this research endeavor?

"Indications on clinicaltrials.gov suggest that this particular medical study is not actively enrolling patients at present, having been first posted in 2006 and last updated in 2008. Thankfully, there are 32 other trials currently recruiting for participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Visual Feedback Goggle for Positional Vertigo Treatment

2006. "Visual Feedback Goggle for Positional Vertigo Treatment". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00729885.

All > Vestibular Migraine